Bristol-Myers Squibb stock jumps on schizophrenia drug approval
Bristol-Myers Squibb shares rose in premarket trade on Friday after the Food and Drug Administration approved a schizophrenia drug.
Chinese stocks could surge higher as investors get ‘FOMO,’ Goldman Sachs says
International investors are getting increasingly concerned about missing out on the rally that was sparked by the unveiling of the People’s Bank of China’s far-reaching...
Satellite-TV rivals DirecTV, Dish reportedly in advanced merger talks
The Wall Street Journal reported DirecTV could acquire rival Dish, creating one of the nation’s largest pay-TV providers, in a deal that could be announced...
China ETFs set for best week on record after Beijing fires policy ‘bazooka’ to boost economy. Is it time to jump in?
China ETFs have surged on the back of a blitz of stimulus measures by the country’s government to revive the world’s second-largest economy.
Cassava Sciences settles SEC charges of ‘misleading’ Alzheimer’s trial claims
Shares of Cassava Sciences Inc. dropped more than 10% in the extended session Thursday after announcing a settlement with U.S. securities regulators, who had charged...
This company had $1 billion in quarterly AI bookings — and it’s not a chip maker
Accenture’s stock rallied toward a six-month high Thursday, after the management consultant got back to beating earnings expectations and continued to tout itself as a...
Presidential race’s winner may not be clear on election night. Here’s how investors can prepare.
The winner of the tight White House race won’t be determined on the night of Nov. 5, a UBS strategist said Thursday, but investors have...
Why a corporate tax hike wouldn’t sink S&P 500 profits and stocks
About half of large U.S. corporations don’t pay any income tax in an average year
These tips for investing in mutual funds and ETFs can heap profits on your plate
China stocks, energy sector and bonds see strong investor demand.